Project Grant HT94252411087
Award Date
12/1/24
Completion Date
11/30/26
Dollars Obligated
$285K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $869,193 to the University of Chicago to conduct research on identifying the pathogenesis of monosomy 7 in bone marrow failure. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical discoveries in this specialized medical domain. The award has a performance period...
The University of Illinois has been awarded a $1,465,443 federal Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420). The funding will support advanced biomedical research focused on the "Promise of Epigenetic Therapy for Refractory Testicular Germ Cell Tumors" over a 3-year period from September 1, 2025 to August 31, 2028. The Military Medical Research and Development program provides funding for innovative medical...
This federal Project Grant award, valued at $1,306,778.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the funding will support a research project titled "IMMUNOLOGIC DRIVERS OF LINEAGE BIAS IN TP53-MUTANT ACUTE LEUKEMIA" conducted by the University of...
This Project Grant award of $639,600.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support research by the University of Illinois to investigate the role of osteopontin-high macrophages in protecting against metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma. The research project will be conducted over a period of approximately 3 years, from August 1, 2024 to July 31, 2027. The University of...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,602,572.00 in funding to the University of Illinois to support research on the role of the novel hexokinase HKDC1 in hepatocellular carcinoma. The award has a performance period from July 15, 2024 to July 14, 2027. The University of Illinois, a major public research university in Chicago, will conduct innovative scientific studies to advance...
The University of Chicago will receive $2,624,000 through a Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to investigate the role of amino acid metabolism in pulmonary fibrosis. Through this award, the University of Chicago aims to advance understanding of medical solutions for pulmonary disorders and translate findings into improved patient...
The University of Chicago will receive $1,229,184 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) from July 1, 2022 to June 30, 2025. The funding will support research into microRNA-mediated regulation of prostate cancer biology. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research solutions for battlefield medicine. The University of...
This federal Project Grant award of $1,235,845.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports a research project led by the University of Illinois in Chicago. The project aims to leverage data science methods to deliver individualized treatment effects in metastatic hormone sensitive prostate cancer. The award period runs from August 15, 2025 to August 14, 2028. The Military Medical Research and Development program funds...
The University of Illinois received a $690,539 project grant award from the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2023 through July 31, 2026 to investigate G0S2 as a master regulator of the local estrogenic environment during breast cancer progression and antiestrogen therapy. Through this award, the University will conduct scientific research that aims to transform healthcare for service...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,924 Project Grant to the Trustees of Indiana University to support a 3-year research project titled "EARLY IMMUNOLOGIC PRECISION TYPING AT-RISK FRACTURES TO PREDICT NONUNION". The project aims to characterize the temporal immune/inflammatory biomarker profile in patients with open tibial fractures and develop a predictive model to guide decision-making for musculoskeletal...